Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Dow
Medtronic
McKinsey
Moodys

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NEXPLANON

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for NEXPLANON

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01397097 LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study Completed Bayer Phase 3 2011-09-01 The primary objective is to demonstrate that discontinuation rates in women (ages 18-35 years inclusive) using LCS12 are not higher than those seen in women using ENG subdermal implant over a period of 12 months. Secondary objectives are to observe the bleeding patterns, adverse event profiles and the occurrence of unintended pregnancies. Additionally, data on user satisfaction, IUS expulsions and implant site complications will be collected.
NCT01438736 Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern? Unknown status Merck Sharp & Dohme Corp. Phase 4 2011-09-01 The purpose of the study is to examine how well three months preceding use of Cerazette progestin only pill predicts the bleeding pattern during following Nexplanon implant use.
NCT01438736 Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern? Unknown status VL-Medi Oy Phase 4 2011-09-01 The purpose of the study is to examine how well three months preceding use of Cerazette progestin only pill predicts the bleeding pattern during following Nexplanon implant use.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NEXPLANON

Condition Name

Condition Name for NEXPLANON
Intervention Trials
Contraception 10
HIV 4
Immune Cells (Mucosal and Systemic) 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for NEXPLANON
Intervention Trials
Hemorrhage 3
Uterine Hemorrhage 1
Opioid-Related Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for NEXPLANON

Trials by Country

Trials by Country for NEXPLANON
Location Trials
United States 10
United Kingdom 5
Australia 4
Finland 2
Sweden 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for NEXPLANON
Location Trials
Georgia 2
Colorado 2
Pennsylvania 2
Kentucky 1
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for NEXPLANON

Clinical Trial Phase

Clinical Trial Phase for NEXPLANON
Clinical Trial Phase Trials
Phase 4 9
Phase 3 2
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for NEXPLANON
Clinical Trial Phase Trials
Completed 5
Not yet recruiting 5
Recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for NEXPLANON

Sponsor Name

Sponsor Name for NEXPLANON
Sponsor Trials
University of Pittsburgh 5
Merck Sharp & Dohme Corp. 3
University of Colorado, Denver 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for NEXPLANON
Sponsor Trials
Other 24
Industry 4
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Moodys
Merck
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.